Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci.

PubWeight™: 3.41‹?› | Rank: Top 1%

🔗 View Article (PMID 1080772)

Published in J Immunol on October 01, 1975

Authors

H D Caldwell, C C Kuo, G E Kenny

Articles citing this

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00

Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82

Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53

High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55

Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med (1989) 3.03

Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03

Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93

Antigenic diversity of Chlamydia psittaci of mammalian origin determined by microimmunofluorescence. Infect Immun (1985) 1.84

Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun (2013) 1.82

Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun (2006) 1.67

Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A (2006) 1.63

Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun (2004) 1.59

Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis. Infect Immun (1982) 1.56

Structural and antigenic analysis of Chlamydia pneumoniae. Infect Immun (1990) 1.52

Reticulate bodies as single antigen in Chlamydia trachomatis serology with microimmunofluorescence. J Clin Microbiol (1979) 1.50

Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci U S A (1987) 1.40

Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun (1986) 1.38

Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol (1989) 1.37

Molecular characterization of Chlamydia trachomatis and Chlamydia psittaci plasmids. Infect Immun (1986) 1.35

Serological cross-reactions between Acinetobacter calcoaceticus and chlamydiae. J Clin Microbiol (1979) 1.31

Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci. J Clin Microbiol (1988) 1.29

Caulobacter crescentus cell envelope: effect of growth conditions on murein and outer membrane protein composition. J Bacteriol (1978) 1.26

Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun (1994) 1.22

Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure. Infect Immun (2008) 1.17

Identification of lectin-binding proteins in Chlamydia species. Infect Immun (1990) 1.15

Cytochemical localization of glycogen in Chlamydia trachomatis inclusions. J Bacteriol (1995) 1.13

Effect of proteolytic cleavage of surface-exposed proteins on infectivity of Chlamydia trachomatis. Infect Immun (1985) 1.11

Comparison of Chlamydia psittaci isolates by restriction endonuclease and DNA probe analyses. Infect Immun (1988) 1.06

Partial purification and characterization of the major species-specific protein antigens of Rickettsia typhi and Rickettsia prowazekii identified by rocket immunoelectrophoresis. Infect Immun (1981) 1.05

The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes. Infect Immun (1987) 0.97

Application of charge shift electrophoresis to antigenic analysis of mycoplasmic membranes by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1978) 0.92

Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific chlamydial epitope. Infect Immun (1987) 0.92

Comparison of enzyme linked immunosorbent assay and enzyme linked fluorescence immunoassay for detection of antibodies against Chlamydia trachomatis. J Clin Pathol (1985) 0.89

Biological characterization of Chlamydia trachomatis plasticity zone MACPF domain family protein CT153. Infect Immun (2010) 0.87

Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun (1998) 0.86

Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis. Front Immunol (2015) 0.85

Detection of Rickettsia rickettsii antibodies in human sera by crossed immunoelectrophoresis. J Clin Microbiol (1983) 0.79

Survey, Culture, and Genome Analysis of Ocular Chlamydia trachomatis in Tibetan Boarding Primary Schools in Qinghai Province, China. Front Cell Infect Microbiol (2017) 0.75

Growth of host cells and Chlamydia trachomatis in medium containing serum from 16-week-old calves. J Clin Microbiol (1983) 0.75

Articles by these authors

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03

Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52

Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08

Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun (1989) 5.75

Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64

Chlamydiae. Annu Rev Microbiol (1980) 5.47

Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29

Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82

Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74

Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53

Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33

Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25

Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol (1997) 3.66

Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66

Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64

Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56

Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50

Effect of polycations, polyanions and neuraminidase on the infectivity of trachoma-inclusin conjunctivitis and lymphogranuloma venereum organisms HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunction. Infect Immun (1973) 3.46

CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun (1995) 3.45

Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44

Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34

Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23

Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22

Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15

Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun (1990) 3.13

Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12

Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11

Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun (1982) 3.09

Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother (1986) 3.08

Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med (1989) 3.03

Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00

A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93

Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia. Infect Immun (1972) 2.93

Heat-lability and organic solvent-solubility of mycoplasma antigens. Ann N Y Acad Sci (1967) 2.92

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90

Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87

Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78

Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76

Structural analysis of chlamydial major outer membrane proteins. Infect Immun (1982) 2.74

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71

Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis (2000) 2.63

Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61

Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58

Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53

Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49

Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49

Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48

Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39

Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38

Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37

Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34

Cloning and sequence analysis of the major outer membrane protein genes of two Chlamydia psittaci strains. Infect Immun (1989) 2.32

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28

Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26

Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24

Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24

Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24

TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19

Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. J Bacteriol (1966) 2.15

Serological comparison of ten glycolytic Mycoplasma species. J Bacteriol (1969) 2.13

Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13

Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis (1973) 2.11

Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol (1999) 2.06

Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06

Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03

Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02

Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother (1986) 2.01

Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96

Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence. Infect Immun (1984) 1.93

Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91

Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89

Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis (1993) 1.89

Differential effect of trypsin on infectivity of Chlamydia trachomatis: loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV. Infect Immun (1988) 1.89

Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87

A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87

Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am J Med (1990) 1.86

Characterization of the group antigen of Chlamydia trachomatis. Infect Immun (1971) 1.86

Serological response to Chlamydia pneumoniae infection. J Clin Microbiol (1990) 1.86

Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet (1988) 1.86

Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science (1985) 1.85

Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A (2001) 1.85

Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies. Infect Immun (1985) 1.84

Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis. J Bacteriol (1987) 1.84

B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J (1993) 1.82

Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay. J Clin Microbiol (1985) 1.79

Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun (1987) 1.76

Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis (1987) 1.76

Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun (1997) 1.74

Antigenic groupings of 90 rhinovirus serotypes. Infect Immun (1982) 1.73

Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J Immunol (1975) 1.73

Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72

Morphology and ultrastructure of Mycoplasma pneumoniae spherules. J Bacteriol (1971) 1.68